Challenges Involved in Incorporating Personalised Treatment Plan as Routine Care of Patients with Diabetes

References

• Parivallal T.Diabetes in Ancient India. In: Type 2 Diabetes in South Asians: Epidemiology, Risk Factors and Prevention. Mohan V, Rao GHR,editors. Under the Aegis of SASAT. Jaypee Brothers Medical Publishers; 2006:97–103.
   Google Scholar
• Himsworth HP. Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types. The Lancet. 1936;227(5864):127–130. doi:10.1016/S0140-6736(01)36134-2
   Google Scholar
• Chung WK, Erion K, Florez JC, et al. Precision Medicine in Diabetes: a Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2020; 43: 1617–1635.
   PubMed Web of Science ®Google Scholar
• Mohan V, Unnikrishnan R. Precision diabetes: where do we stand today? Indian J Med Res. 2018;148(5):472–475. doi:10.4103/ijmr.IJMR_1628_18
   Web of Science ®Google Scholar
• Ahlqvist E, Storm P, Käräjämäki A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6(5):361–369. doi:10.1016/S2213-8587(18)30051-2
   PubMed Web of Science ®Google Scholar
• Zou X, Zhou X, Zhu Z, Ji L. Novel subgroups of patients with adult-onset diabetes in Chinese and US populations. Lancet Diabetes Endocrinol. 2019;7:9–11. doi:10.1016/S2213-8587(18)30316-4
   Web of Science ®Google Scholar
• Bello-Chavolla OY, Bahena-López JP, Vargas-Vázquez A, et al. Metabolic syndrome study group; group of study CAIPaDi. CLINICAL characterization of data-driven diabetes subgroups in Mexicans using a reproducible machine learning approach. BMJ Open Diabetes Res Care. 2020;8:e001550.
   Web of Science ®Google Scholar
• Zaharia OP, Strassburger K, Strom A, et al. German Diabetes Study Group. Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol. 2019;7(9):684–694. doi:10.1016/S2213-8587(19)30187-1
   PubMed Web of Science ®Google Scholar
• Anjana RM, Baskar V, Nair ATN, et al. Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: a data-driven cluster analysis: the INSPIRED study. BMJ Open Diabetes Res Care. 2020;8:e001506. doi:10.1136/bmjdrc-2020-001506
   Web of Science ®Google Scholar
• Dennis JM, Shields BM, Henley WE, Jones AG, Hattersley AT. Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data. Lancet Diabetes Endocrinol. 2019;7:442–451. doi:10.1016/S2213-8587(19)30087-7
   PubMed Web of Science ®Google Scholar
• Dhanwal DK, Agarwal S, Garg S, Agarwal P. Clinical & immunological profile of newly diagnosed patients with youth onset diabetes mellitus. Indian J Med Res. 2014;140:356–360.
   Web of Science ®Google Scholar
• Tattersall RB, Fajans SS. A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people. Diabetes. 1975;24:44–53. doi:10.2337/diab.24.1.44
   PubMed Web of Science ®Google Scholar
• Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab. 2008;4:200–213. doi:10.1038/ncpendmet0778
   PubMedGoogle Scholar
• Ellard S, Colclough K, Patel KA, Hattersley AT. Prediction algorithms: pitfalls in interpreting genetic variants of autosomal dominant monogenic diabetes. J Clin Invest. 2020;130:14–16. doi:10.1172/JCI133516
   Web of Science ®Google Scholar
• Aarthy R, Aston-Mourney K, Mikocka-Walus A, et al. Clinical features, complications and treatment of rarer forms of maturity-onset diabetes of the young (MODY) - a review. J Diabetes Complications. 2021;35:107640. doi:10.1016/j.jdiacomp.2020.107640
   Web of Science ®Google Scholar
• Iliodromiti S, Ghouri N, Celis-Morales CA, Sattar N, Lumsden MA, Gill JM. Should physical activity recommendations for South Asian adults be ethnicity-specific? Evidence from a cross-sectional study of South Asian and White European Men and Women. PLoS One. 2016;11:e0160024. doi:10.1371/journal.pone.0160024
   PubMed Web of Science ®Google Scholar
• Schwartz SS, Epstein S, Corkey BE, Grant SF, Gavin JR 3rd. Aguilar RB the Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the ß-Cell-Centric Classification Schema Diabetes Care. 2016;39:179–186.
   PubMed Web of Science ®Google Scholar
• Saisho Y. Changing the concept of Type 2 diabetes: beta cell workload hypothesis revisited. Endocr Metab Immune Disord Drug Targets. 2019;19:121–127. doi:10.2174/1871530318666180821161825
   PubMed Web of Science ®Google Scholar
• Saisho Y. An emerging new concept for the management of type 2 diabetes with a paradigm shift from the glucose-centric to beta cell-centric concept of diabetes - an Asian perspective. Expert Opin Pharmacother. 2020;21(13):1565–1578. doi:10.1080/14656566.2020.1776262
   PubMed Web of Science ®Google Scholar
• DeFronzo, From the triumvirate to the ominous octet (Banting Lecture), Diabetes, 2009
   Google Scholar
• Edelman SV, Polonsky WH. Type 2 diabetes in the real world: the elusive nature of glycemic control. Diabetes Care. 2017;40(11):1425–1432. doi:10.2337/dc16-1974
   PubMed Web of Science ®Google Scholar
• Narayan KMV, Kanaya AM. Why are South Asians prone to type 2 diabetes? A hypothesis based on underexplored pathways. Diabetologia. 2020;63(6):1103–1109. doi:10.1007/s00125-020-05132-5
   Web of Science ®Google Scholar
• Gan S, Dawed AY, Donnelly LA, et al. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in white and Asian patients with diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care. 2020;43(8):1948–1957. doi:10.2337/dc19-2419
   PubMed Web of Science ®Google Scholar
• Florez JC. The pharmacogenetics of metformin. Diabetologia. 2017;60(9):1648–1655. doi:10.1007/s00125-017-4335-y
   PubMed Web of Science ®Google Scholar
• American Diabetes Association 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes—2021. Diabetes Care. 2021;44(Supplement 1):S111–S124. doi:10.2337/dc21-S009
   PubMed Web of Science ®Google Scholar